Hock R - Search Results

1

International pooled patient-level meta-analysis of ketamine infusion for depression: In search of clinical moderators.

Price RB, Kissel N, Baumeister A, Rohac R, Woody ML, Ballard ED, Zarate CA Jr, Deakin W, Abdallah CG, Feder A, Charney DS, Grunebaum MF, Mann JJ, Mathew SJ, Gallagher B, McLoughlin DM, Murrough JW, Muthukumaraswamy S, McMillan R, Sumner R, Papakostas G, Fava M, Hock R, Phillips JL, Blier P, Shiroma P, Šóš P, Su TP, Chen MH, Tiger M, Lundberg J, Wilkinson ST, Wallace ML. Price RB, et al. Among authors: hock r. Mol Psychiatry. 2022 Dec;27(12):5096-5112. doi: 10.1038/s41380-022-01757-7. Epub 2022 Sep 7. Mol Psychiatry. 2022. PMID: 36071111 Free PMC article.

2

Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depression.

Salloum NC, Fava M, Freeman MP, Flynn M, Hoeppner B, Hock RS, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Salloum NC, et al. Depress Anxiety. 2019 Mar;36(3):235-243. doi: 10.1002/da.22875. Epub 2018 Dec 30. Depress Anxiety. 2019. PMID: 30597688 Clinical Trial.

3

Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depression.

Salloum NC, Fava M, Hock RS, Freeman MP, Flynn M, Hoeppner B, Cusin C, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Papakostas GI. Salloum NC, et al. J Affect Disord. 2020 Jan 1;260:131-139. doi: 10.1016/j.jad.2019.09.017. Epub 2019 Sep 3. J Affect Disord. 2020. PMID: 31494365 Free PMC article.

4

Body Mass Index as a Moderator of Treatment Response to Ketamine for Major Depressive Disorder.

Freeman MP, Hock RS, Papakostas GI, Judge H, Cusin C, Mathew SJ, Sanacora G, Iosifescu DV, DeBattista C, Trivedi MH, Fava M. Freeman MP, et al. J Clin Psychopharmacol. 2020 May/Jun;40(3):287-292. doi: 10.1097/JCP.0000000000001209. J Clin Psychopharmacol. 2020. PMID: 32332464 Free PMC article. Clinical Trial.

5

Efficacy of Esketamine Augmentation in Major Depressive Disorder: A Meta-Analysis.

Papakostas GI, Salloum NC, Hock RS, Jha MK, Murrough JW, Mathew SJ, Iosifescu DV, Fava M. Papakostas GI, et al. J Clin Psychiatry. 2020 May 26;81(4):19r12889. doi: 10.4088/JCP.19r12889. J Clin Psychiatry. 2020. PMID: 32459407

6

Double-blind, placebo-controlled, proof-of-concept trial of a kappa-selective opioid receptor antagonist augmentation in treatment-resistant depression.

Fava M, Mazzone E, Freeman M, Flynn M, Judge H, Hoeppner B, Hock RS, Shui A, Macaluso M, Morrison MF, Carpenter LL, Shelton R, Zajecka J, Papakostas GI. Fava M, et al. Among authors: hock rs. Ann Clin Psychiatry. 2020 Feb;32(4):18-26. doi: 10.12788/acp.0003. Ann Clin Psychiatry. 2020. PMID: 33125454

7

The effect of single administration of intravenous ketamine augmentation on suicidal ideation in treatment-resistant unipolar depression: Results from a randomized double-blind study.

Feeney A, Hock RS, Freeman MP, Flynn M, Hoeppner B, Iosifescu DV, Trivedi MH, Sanacora G, Mathew SJ, Debattista C, Ionescu DF, Fava M, Papakostas GI. Feeney A, et al. Eur Neuropsychopharmacol. 2021 Aug;49:122-132. doi: 10.1016/j.euroneuro.2021.04.024. Epub 2021 Jun 3. Eur Neuropsychopharmacol. 2021. PMID: 34090255 Free PMC article. Clinical Trial.

8

Vortioxetine Versus Placebo for Major Depressive Disorder: A Comprehensive Analysis of the Clinical Trial Dataset.

Iovieno N, Papakostas GI, Feeney A, Fava M, Mathew SJ, Iosifescu DI, Murrough JW, Macaluso M, Hock RS, Jha MK. Iovieno N, et al. J Clin Psychiatry. 2021 Jun 15;82(4):20r13682. doi: 10.4088/JCP.20r13682. J Clin Psychiatry. 2021. PMID: 34133089

9

Antidepressants in children and adolescents with major depressive disorder and the influence of placebo response: A meta-analysis.

Feeney A, Hock RS, Fava M, Hernández Ortiz JM, Iovieno N, Papakostas GI. Feeney A, et al. J Affect Disord. 2022 May 15;305:55-64. doi: 10.1016/j.jad.2022.02.074. Epub 2022 Mar 3. J Affect Disord. 2022. PMID: 35247482 Review.

10

Rapidity of Symptom Improvement With Intranasal Esketamine for Major Depressive Disorder: A Systematic Review and Meta-Analysis.

Hock RS, Feeney A, Iovieno N, Murrough JW, Mathew SJ, Iosifescu DV, Fava M, Jha MK, Papakostas GI. Hock RS, et al. J Clin Psychiatry. 2022 Dec 12;84(1):21r14086. doi: 10.4088/JCP.21r14086. J Clin Psychiatry. 2022. PMID: 36516320

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page